StockTipsArenaBeta

BUY Biocon Ltd — Prashant P. Sawant

BUYBiocon Ltd
Biocon share price target & all analyst calls

byPrashant P. SawantHorizon: NA (inferred Intraday)9 Jul 2026, 1:02 pm ISTvia CNBC Awaaz.

Entry₹403.7Inferred
Target₹415
Total upside +2.80% (call closed)
Stop loss₹395-2.16% risk
At expiry₹404.69 Jul 2026, 3:20 pm
Expired+0.22%
Follow Prashant P. Sawant for new calls(5% target hit, 19 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:33 pm IST
1 supporting0 opposing
Supports the BUY call (1)

Biocon announced the publication of pivotal clinical data supporting the effectiveness of Yesafili, a biosimilar to Eylea®.

NSE · Press Release·9 Jul · today

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Prashant P. Sawant

Every call and its outcome